BioCryst Pharmaceuticals Inc (NAS:BCRX)
$ 7.82 -0.37 (-4.52%) Market Cap: 1.62 Bil Enterprise Value: 2.18 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 75/100

Q1 2020 BioCryst Pharmaceuticals Inc Earnings Call Transcript

May 06, 2020 / 12:30PM GMT
Release Date Price: $3.86 (-2.28%)
Operator

Good morning, ladies and gentlemen. And welcome to the BioCryst First Quarter 2020 Earnings Call.

(Operator Instruction]

As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. John Bluth at Biocryst.

John D. Bluth
BioCryst Pharmaceuticals, Inc. - SVP of IR & Corporate Communications

Thanks, Whitney. Good morning. And welcome to BioCryst's First Quarter 2020 Corporate Update and Financial Results Conference Call. Today's press release and slides are available on our website.

Participating with me today are: CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Medical Officer, Dr. Bill Sheridan; Chief Business Officer, Megan Sniecinski; and Chief Commercial Officer, Charlie Gayer. Following our remarks, we will answer your questions.

Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial information as well as the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot